Physician profile
Joseph S Gondusky
NPI 1295803567
$1,187,299.69
in general payments reported to CMS, 2019-2025
13 companies · $364K in 2025
The $364K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179K · 2020: $51K · 2021: $83K · 2022: $261K · 2023: $67K · 2024: $182K · 2025: $364K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $425K · Consulting Fee: $163K · Travel and Lodging: $20K · Food and Beverage: $5,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $424,602.50 |
| Consulting Fee | $163,424.72 |
| Travel and Lodging | $19,792.30 |
| Food and Beverage | $5,525.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $767,232.08 | 2020-2025 | Attune, Actis, Summit |
| Zimmer Biomet Holdings, INC. | $175,853.51 | 2019-2025 | Rosa, G7, Persona |
| Medical Device Business Services, INC. | $168,399.31 | 2019-2025 | Actis, Attune, Velys |
| Kyocera Medical Technologies, INC. | $69,927.57 | 2024-2025 | |
| Depuy Synthes Sales INC. | $3,781.57 | 2019-2025 | Attune, Actis, Velys |
| Stryker Corporation | $1,523.24 | 2021-2025 | Mako, Insignia |
| Insight Medical Systems, INC. | $360.58 | 2024 | Arvis |
| Innovation Technologies INC | $102.20 | 2022 | |
| Bioventus LLC | $33.63 | 2020 | |
| Fidia Pharma USA INC. | $30.80 | 2022-2023 | Hymovis |
| Smith+Nephew, INC. | $25.60 | 2019 | |
| Medacta USA, INC. | $21.98 | 2022 | |
| Heraeus Medical, LLC. | $7.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gondusky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.